1 |
Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers |
|
| | Ghofraan Abdulsalam Atallah, Nirmala Chandralega Kampan, Kah Teik Chew, Norfilza Mohd Mokhtar, Reena Rahayu Md Zin, Mohamad Nasir bin Shafiee, Nor Haslinda binti Abd. Aziz | | | International Journal of Molecular Sciences. 2023; 24(3): 1973 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients |
|
| | Xiaofeng Li, Qiu Wang, Zhicheng Wu, Jiantong Zheng, Ling Ji, Osamah Ibrahim Khalaf | | | Computational and Mathematical Methods in Medicine. 2022; 2022: 1 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis |
|
| | Caihong Li, Qin Wang, Youzhen Luo, Juan Xiang, Carmela Ricciardelli | | | Analytical Cellular Pathology. 2022; 2022: 1 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation |
|
| | Yuzi Zhao, Jie Pi, Lihua Liu, Wenjie Yan, Shufang Ma, Li Hong | | | Cancer Management and Research. 2021; Volume 13: 707 | | | [Pubmed] [Google Scholar] [DOI] | | 5 |
Recent advances in gynecologic oncopathologyGenito Urinary Pathology |
|
| | Bharat Rekhi | | | Indian Journal of Pathology and Microbiology. 2020; 63(5): 5 | | | [Pubmed] [Google Scholar] [DOI] | |
|